News | July 06, 2022
Vaccizone selects Exothera for GMP manufacturing of its SARS?CoV?2 vaccine
Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells
Vaccizone’s ASC Technology is an enhanced antigen/bioactive delivery method based on Antigen Presenting Cells
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone
The proposed transaction involves the sale of the global biosimilars portfolio of Viatris to Biocon Biologics
The company has launched indigenously produced Dual Chamber Bags of global standards in India at a pocket-friendly price
Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).
The abstract is about the cohort A, stage I of the ongoing global phase ? trial that evaluating the safety and efficacy of Catumaxomab in advanced GC patients with peritoneal metastasis
68% of patients receiving Kymriah in the ELARA trial experienced a complete response, with an 86% overall response rate, along with a remarkable safety profile
Five patient-first principles to provide the highest standard of healthcare
Successfully removed peanut from the child’s left lung through bronchoscopy
Subscribe To Our Newsletter & Stay Updated
